Your browser doesn't support javascript.
loading
Acute Kidney Injury Patterns Following Transplantation of Steatotic Liver Allografts.
Jadlowiec, Caroline; Smith, Maxwell; Neville, Matthew; Mao, Shennen; Abdelwahab, Dina; Reddy, Kunam; Moss, Adyr; Aqel, Bashar; Taner, Timucin.
Afiliación
  • Jadlowiec C; Division of Transplant Surgery, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Smith M; Division of Anatomic Pathology, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Neville M; Instructor in Biostatistics, Mayo Clinic College of Medicine, Phoenix, AZ 85054, USA.
  • Mao S; Division of Transplant Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.
  • Abdelwahab D; Division of Nephrology, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Reddy K; Division of Transplant Surgery, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Moss A; Division of Transplant Surgery, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Aqel B; Division of Transplant Hepatology, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Taner T; Division of Transplant Surgery, William J von Liebig Transplant Center, Rochester, MN 55902, USA.
J Clin Med ; 9(4)2020 Mar 30.
Article en En | MEDLINE | ID: mdl-32235545
ABSTRACT

BACKGROUND:

Steatotic grafts are increasingly being used for liver transplant (LT); however, the impact of graft steatosis on renal function has not been well described.

METHODS:

A total of 511 allografts from Mayo Clinic Arizona and Minnesota were assessed. We evaluated post-LT acute kidney injury (AKI) patterns, perioperative variables and one-year outcomes for patients receiving moderately steatotic allografts (>30% macrovesicular steatosis, n = 40) and compared them to non-steatotic graft recipients.

RESULTS:

Post-LT AKI occurred in 52.5% of steatotic graft recipients versus 16.7% in non-steatotic recipients (p < 0.001). Ten percent of steatotic graft recipients required new dialysis post-LT (p = 0.003). At five years, there were no differences for AKI vs. no AKI patient survival (HR 0.95, 95% CI 0.08-10.6, p = 0.95) or allograft survival (HR 1.73, 95% CI 0.23-13.23, p = 0.59) for those using steatotic grafts. Lipopeliosis on biopsy was common in those who developed AKI (61.0% vs. 31.6%, p = 0.04), particularly when the Model for End-Stage Liver Disease (MELD) was ≥20 (88.9%; p = 0.04). Lipopeliosis was a predictor of post-LT AKI (OR 6.0, 95% CI 1.1-34.6, p = 0.04).

CONCLUSION:

One-year outcomes for moderately steatotic grafts are satisfactory; however, a higher percentage of post-LT AKI and initiation of dialysis can be expected. Presence of lipopeliosis on biopsy appears to be predictive of post-LT AKI.
Palabras clave

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: J Clin Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: J Clin Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos